323 related articles for article (PubMed ID: 35650448)
41. Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach.
Cheng YH; He C; Riviere JE; Monteiro-Riviere NA; Lin Z
ACS Nano; 2020 Mar; 14(3):3075-3095. PubMed ID: 32078303
[TBL] [Abstract][Full Text] [Related]
42. Chitosan Anchored Nanoparticles in Current Drug Development Utilizing Computer-Aided Pharmacokinetic Modeling: Case Studies for Target Specific Cancer Treatment and Future Prospective.
Roy H; Nayak BS; Nandi S
Curr Pharm Des; 2020; 26(15):1666-1675. PubMed ID: 32013823
[TBL] [Abstract][Full Text] [Related]
43. Anatomy and Physiology of Multiscale Modeling and Simulation in Systems Medicine.
Mizeranschi A; Groen D; Borgdorff J; Hoekstra AG; Chopard B; Dubitzky W
Methods Mol Biol; 2016; 1386():375-404. PubMed ID: 26677192
[TBL] [Abstract][Full Text] [Related]
44. Toward Multiscale Modeling of Proteins and Bioagglomerates: An Orientation-Sensitive Diffusion Model for the Integration of Molecular Dynamics and the Discrete Element Method.
Depta PN; Jandt U; Dosta M; Zeng AP; Heinrich S
J Chem Inf Model; 2019 Jan; 59(1):386-398. PubMed ID: 30550276
[TBL] [Abstract][Full Text] [Related]
45. Biophysical experiments and simulation in nanoparticle-based drug delivery systems.
Thewalt J; Tieleman DP
J Drug Target; 2016 Nov; 24(9):768-773. PubMed ID: 27608728
[TBL] [Abstract][Full Text] [Related]
46. Nanoscale Drug Delivery Systems for Glaucoma: Experimental and
Sharma S; Bhatia V
Curr Top Med Chem; 2021; 21(2):115-125. PubMed ID: 32962618
[TBL] [Abstract][Full Text] [Related]
47.
Jose J; S S; Mathew B; Parambi DGT
Comb Chem High Throughput Screen; 2022; 25(12):1991-2000. PubMed ID: 34986768
[TBL] [Abstract][Full Text] [Related]
48. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
49. In situ cellular hitchhiking of nanoparticles for drug delivery.
Udofa E; Zhao Z
Adv Drug Deliv Rev; 2024 Jan; 204():115143. PubMed ID: 38008185
[TBL] [Abstract][Full Text] [Related]
50. Overcoming in vivo barriers to targeted nanodelivery.
Chrastina A; Massey KA; Schnitzer JE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):421-37. PubMed ID: 21538941
[TBL] [Abstract][Full Text] [Related]
51. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
Babu A; Templeton AK; Munshi A; Ramesh R
AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
[TBL] [Abstract][Full Text] [Related]
52. The Role of
Jayasinghe MK; Lee CY; Tran TTT; Tan R; Chew SM; Yeo BZJ; Loh WX; Pirisinu M; Le MTN
Front Digit Health; 2022; 4():838590. PubMed ID: 35373184
[TBL] [Abstract][Full Text] [Related]
53. Multiscale modeling meets machine learning: What can we learn?
Peng GCY; Alber M; Tepole AB; Cannon WR; De S; Dura-Bernal S; Garikipati K; Karniadakis G; Lytton WW; Perdikaris P; Petzold L; Kuhl E
Arch Comput Methods Eng; 2021 May; 28(3):1017-1037. PubMed ID: 34093005
[TBL] [Abstract][Full Text] [Related]
54. An analysis platform for multiscale hydrogeologic modeling with emphasis on hybrid multiscale methods.
Scheibe TD; Murphy EM; Chen X; Rice AK; Carroll KC; Palmer BJ; Tartakovsky AM; Battiato I; Wood BD
Ground Water; 2015; 53(1):38-56. PubMed ID: 24628122
[TBL] [Abstract][Full Text] [Related]
55. Computational design and multiscale modeling of a nanoactuator using DNA actuation.
Hamdi M
Nanotechnology; 2009 Dec; 20(48):485501. PubMed ID: 19880974
[TBL] [Abstract][Full Text] [Related]
56. Design of a framework for modeling, integration and simulation of physiological models.
Erson E; Cavusoglu M
Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():1485-9. PubMed ID: 21096363
[TBL] [Abstract][Full Text] [Related]
57. Multiscale modeling of the neuromuscular system: Coupling neurophysiology and skeletal muscle mechanics.
Röhrle O; Yavuz UŞ; Klotz T; Negro F; Heidlauf T
Wiley Interdiscip Rev Syst Biol Med; 2019 Nov; 11(6):e1457. PubMed ID: 31237041
[TBL] [Abstract][Full Text] [Related]
58. Data Analytics Approach for Rational Design of Nanomedicines with Programmable Drug Release.
Mullis AS; Broderick SR; Binnebose AM; Peroutka-Bigus N; Bellaire BH; Rajan K; Narasimhan B
Mol Pharm; 2019 May; 16(5):1917-1928. PubMed ID: 30973741
[TBL] [Abstract][Full Text] [Related]
59. Computational model of silica nanoparticle penetration into tumor spheroids: Effects of methoxy and carboxy PEG surface functionalization and hyperthermia.
Nagesetti A; Dulikravich GS; Orlande HRB; Colaco MJ; McGoron AJ
Int J Numer Method Biomed Eng; 2021 Aug; 37(8):e3504. PubMed ID: 34151543
[TBL] [Abstract][Full Text] [Related]
60. Rational design of liposomal drug delivery systems, a review: Combined experimental and computational studies of lipid membranes, liposomes and their PEGylation.
Bunker A; Magarkar A; Viitala T
Biochim Biophys Acta; 2016 Oct; 1858(10):2334-2352. PubMed ID: 26915693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
